Literature DB >> 16432677

Levels of vancomycin in the cerebral interstitial fluid after severe head injury.

Anselmo Caricato1, Mariano Pennisi2, Aldo Mancino2, Gianluca Vigna2, Claudio Sandroni2, Andrea Arcangeli2, Massimo Antonelli2.   

Abstract

OBJECTIVE: To evaluate the concentrations of vancomycin in the cerebral interstitial fluid after intravenous administration by multiple boli.
DESIGN: Prospective non randomized study
SETTING: University hospital general ICU. PATIENTS: Four patients undergone to craniotomy for evacuation of cerebral posttraumatic hemorrhage, who developed pneumonia 4-7 days from the injury
METHODS: Two microdialysis catheters were placed in each patient: one in the edematous brain surrounding the focal lesion and one in the subcutaneous tissue of abdomen. Levels of vancomycin were measured in serum and in the microdialysates samples.
RESULTS: Plasmatic concentration of 10-15 microg/ml in the trough level was obtained after four administrations of vancomycin. Levels of vancomycin in the subcutaneous tissue was above minimum inhibitory concentrations in all patients after the second administration. Mean serum/brain ratio was 8%. Cerebral interstitial concentration of vancomycin was never above minimum inhibitory concentrations; its maximum value was 1.2 microg/ml.
CONCLUSIONS: In edematous brain close to a posttraumatic hemorrhage the levels of vancomycin do not differ from that in healthy subjects. At these plasmatic concentrations cerebral interstitial levels of vancomycin were insufficient while subcutaneous interstitial levels were effective for clinical use.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16432677     DOI: 10.1007/s00134-005-0015-3

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  18 in total

Review 1.  Analytical considerations for microdialysis sampling.

Authors:  M I Davies; J D Cooper; S S Desmond; C E Lunte; S M Lunte
Journal:  Adv Drug Deliv Rev       Date:  2000-12-15       Impact factor: 15.470

Review 2.  Considerations in the use of cerebrospinal fluid pharmacokinetics to predict brain target concentrations in the clinical setting: implications of the barriers between blood and brain.

Authors:  Elizabeth C M de Lange; Meindert Danhof
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

3.  Radioimmunoassay for the measurement of S9788 in serum and microdialysis samples.

Authors:  C E Mackie; H E English; E Lelievre; B H Gordon; P Génissel; B V Robinson
Journal:  J Pharm Biomed Anal       Date:  1997-04       Impact factor: 3.935

4.  Vancomycin therapeutic drug monitoring: is there a consensus view? The results of a UK National External Quality Assessment Scheme (UK NEQAS) for Antibiotic Assays questionnaire.

Authors:  C M Tobin; J M Darville; A H Thomson; G Sweeney; J F Wilson; A P MacGowan; L O White
Journal:  J Antimicrob Chemother       Date:  2002-11       Impact factor: 5.790

5.  Cerebrospinal fluid penetration and pharmacokinetics of vancomycin administered by continuous infusion to mechanically ventilated patients in an intensive care unit.

Authors:  J Albanèse; M Léone; B Bruguerolle; M L Ayem; B Lacarelle; C Martin
Journal:  Antimicrob Agents Chemother       Date:  2000-05       Impact factor: 5.191

6.  Increased blood-brain barrier permeability of morphine in a patient with severe brain lesions as determined by microdialysis.

Authors:  R Bouw; P Ederoth; J Lundberg; U Ungerstedt; C H Nordström; M Hammarlund-Udenaes
Journal:  Acta Anaesthesiol Scand       Date:  2001-03       Impact factor: 2.105

Review 7.  The therapeutic monitoring of antimicrobial agents.

Authors:  E J Begg; M L Barclay; C J Kirkpatrick
Journal:  Br J Clin Pharmacol       Date:  1999-01       Impact factor: 4.335

Review 8.  Antibiotic pharmacodynamics in cerebrospinal fluid.

Authors:  I Lutsar; G H McCracken; I R Friedland
Journal:  Clin Infect Dis       Date:  1998-11       Impact factor: 9.079

9.  Vancomycin therapy in patients with impaired renal function: a nomogram for dosage.

Authors:  R C Moellering; D J Krogstad; D J Greenblatt
Journal:  Ann Intern Med       Date:  1981-03       Impact factor: 25.391

10.  Prophylactic administration of ceftriaxone for the prevention of meningitis after traumatic pneumocephalus: results of a clinical trial.

Authors:  Behzad Eftekhar; Mohammad Ghodsi; Farideh Nejat; Ebrahim Ketabchi; Babak Esmaeeli
Journal:  J Neurosurg       Date:  2004-11       Impact factor: 5.115

View more
  11 in total

1.  Correlation between brain interstitial and total serum cortisol levels in traumatic brain injury. A preliminary study.

Authors:  J A Llompart-Pou; G Pérez; J Pérez-Bárcena; M Brell; J Ibáñez; M Riesco; J M Abadal; J Homar; P Marsé; J Ibáñez; B Burguera; J M Raurich
Journal:  J Endocrinol Invest       Date:  2010-06       Impact factor: 4.256

2.  Comment on "Levels of vancomycin in the cerebral interstitial fluid after severe head injury" by Caricato et al.

Authors:  Sandra Magnoni; Elisa Roncati Zanier; Nino Stocchetti
Journal:  Intensive Care Med       Date:  2006-05-24       Impact factor: 17.440

3.  Microdialysis study of cefotaxime cerebral distribution in patients with acute brain injury.

Authors:  Claire Dahyot-Fizelier; Denis Frasca; Nicolas Grégoire; Christophe Adier; Olivier Mimoz; Bertrand Debaene; William Couet; Sandrine Marchand
Journal:  Antimicrob Agents Chemother       Date:  2013-04-09       Impact factor: 5.191

4.  Concentrations of Cefuroxime in Brain Tissue of Neurointensive Care Patients.

Authors:  A Hosmann; L C Ritscher; H Burgmann; Z Oesterreicher; W Jäger; S Poschner; E Knosp; A Reinprecht; A Gruber; M Zeitlinger
Journal:  Antimicrob Agents Chemother       Date:  2018-01-25       Impact factor: 5.191

Review 5.  Penetration of Vancomycin into the Cerebrospinal Fluid: A Systematic Review.

Authors:  Jessica E Beach; Jerrold Perrott; Ricky D Turgeon; Mary H H Ensom
Journal:  Clin Pharmacokinet       Date:  2017-12       Impact factor: 6.447

Review 6.  Penetration of drugs through the blood-cerebrospinal fluid/blood-brain barrier for treatment of central nervous system infections.

Authors:  Roland Nau; Fritz Sörgel; Helmut Eiffert
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

7.  Pharmacokinetics of single-dose daptomycin in patients with suspected or confirmed neurological infections.

Authors:  Ravina Kullar; Judy N Chin; David J Edwards; Dennis Parker; William M Coplin; Michael J Rybak
Journal:  Antimicrob Agents Chemother       Date:  2011-04-18       Impact factor: 5.191

8.  Pharmacokinetics of antibiotics or antifungal drugs in intensive care units.

Authors:  Guillaume Dufour; Philippe Montravers
Journal:  Curr Infect Dis Rep       Date:  2009-01       Impact factor: 3.725

Review 9.  Cerebral microdialysis in clinical studies of drugs: pharmacokinetic applications.

Authors:  Richard J Shannon; Keri L H Carpenter; Mathew R Guilfoyle; Adel Helmy; Peter J Hutchinson
Journal:  J Pharmacokinet Pharmacodyn       Date:  2013-03-07       Impact factor: 2.745

10.  Intrathecal and intraventricular antibiotics for postoperative Gram-negative meningitis and ventriculitis.

Authors:  Saad Akhtar Khan; Muhammad Waqas; Usman T Siddiqui; Muhammad Shahzad Shamim; Karim Rizwan Nathani; Rashid Jooma; Faisal Mehmood
Journal:  Surg Neurol Int       Date:  2017-09-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.